The drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients...
The Brotman Baty Institute for Precision Medicine combines the research strengths and capabilities of UW Medicine, Fred...
By launching a bilateral attack on cancer cells, researchers hope to ultimately increase patients’ long-term remission
It Starts With Yes: The Campaign for Seattle Children’s is the largest in Seattle Children’s 110-year history
Beitel assumes role after serving as executive director in the Public Finance Group at JP Morgan
Chaudry assumes role after serving as chief information officer at Cambridge University Hospitals in the United Kingdom
Phase 1 trial aims to increase long-term remission, it is the first on the West Coast to target CD22-positive leukemia
Next-generation sequencing to expand diagnostic information available and guide personalized treatment plans
Findings show certain genetic mutations and family history are common risk factors in children diagnosed with acute...
Phase 1 pilot study utilizes T-cell antigen presenting cells to prolong the persistence of cancer-fighting chimeric antigen...
Please read our press policy before contacting us.
The best way to reach the public relations team is to email email@example.com. To reach us by phone, call 206-987-4500.
Note: This contact information is for members of the media only. For non-media inquiries, call the hospital switchboard at 206-987-2000.
11.17.17 — GeekWire
With cutting-edge immunotherapy treatments opening doors to fight cancer, the outlook for patients today is much better than...
11.16.17 — Xconomy
The researchers and doctors at Seattle Children’s are embarking upon a complicated quest, involving multiple clinical...
11.16.17 — ABC News
Russel and Magda Newman’s son, Nathaniel, was diagnosed with Treacher Collins, an extremely rare congenital craniofacial...